Thyrocare Technologies Ltd(IN:THYROCARE)
₹488.85+3.15 (+0.65%)
IN:THYROCARE
Thyrocare Technologies Ltd financials statements
₹488.85
At close:+3.15 (+0.65%)
Want to see IN:THYROCARE full AI Analyst Report?
Thyrocare Technologies Ltd (THYROCARE) Ratios
4 Followers
Thyrocare Technologies Ltd Ratios
IN:THYROCARE's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:THYROCARE's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.39 | 2.77 | 3.08 | 3.54 | 4.19 |
| Quick Ratio | 2.95 | 2.33 | 2.55 | 3.15 | 3.65 |
| Cash Ratio | 0.35 | 0.15 | 0.10 | 0.23 | 0.21 |
| Solvency Ratio | 1.37 | 1.01 | 1.01 | 1.06 | 2.59 |
| Operating Cash Flow Ratio | 1.97 | 1.57 | 1.85 | 1.68 | 1.76 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 15.68 | 0.00 | 22.68 |
| Net Current Asset Value | ₹ 2.11B | ₹ 1.92B | ₹ 1.62B | ₹ 1.75B | ₹ 1.89B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.04 | 0.07 | 0.04 | 0.03 |
| Debt-to-Equity Ratio | 0.09 | 0.05 | 0.08 | 0.04 | 0.04 |
| Debt-to-Capital Ratio | 0.08 | 0.04 | 0.07 | 0.04 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.28 | 1.27 | 1.22 | 1.18 | 1.15 |
| Debt Service Coverage Ratio | 76.94 | 48.87 | 7.50 | 22.10 | 28.84 |
| Interest Coverage Ratio | 73.89 | 44.30 | 17.33 | 17.92 | 84.82 |
| Debt to Market Cap | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Interest Debt Per Share | 3.37 | 5.19 | 9.08 | 5.32 | 4.36 |
| Net Debt to EBITDA | 0.05 | 0.03 | 0.22 | 0.04 | 0.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 37.35% | 72.20% | 31.62% | 69.01% | 71.18% |
| EBIT Margin | 24.96% | 21.60% | 17.68% | 17.51% | 39.07% |
| EBITDA Margin | 32.02% | 29.64% | 25.90% | 24.86% | 44.86% |
| Operating Profit Margin | 24.96% | 19.66% | 16.76% | 16.43% | 34.14% |
| Pretax Profit Margin | 25.68% | 21.16% | 16.72% | 16.82% | 38.67% |
| Net Profit Margin | 19.67% | 13.31% | 12.37% | 12.24% | 29.91% |
| Continuous Operations Profit Margin | 19.64% | 13.20% | 12.15% | 12.22% | 29.94% |
| Net Income Per EBT | 76.59% | 62.92% | 74.02% | 72.80% | 77.35% |
| EBT Per EBIT | 102.90% | 107.65% | 99.74% | 102.36% | 113.28% |
| Return on Assets (ROA) | 21.82% | 13.21% | 10.99% | 10.19% | 28.99% |
| Return on Equity (ROE) | 27.85% | 16.74% | 13.43% | 12.07% | 33.45% |
| Return on Capital Employed (ROCE) | 32.46% | 23.66% | 17.32% | 15.58% | 37.01% |
| Return on Invested Capital (ROIC) | 24.39% | 14.57% | 12.09% | 11.17% | 28.11% |
| Return on Tangible Assets | 25.65% | 15.79% | 13.12% | 12.13% | 34.77% |
| Earnings Yield | 2.94% | 7.12% | 2.21% | 2.84% | 4.30% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.22 | 8.36 | 12.95 | 6.15 | 6.23 |
| Payables Turnover | 7.95 | 2.51 | 9.75 | 6.80 | 10.27 |
| Inventory Turnover | 10.72 | 3.55 | 8.23 | 5.40 | 4.93 |
| Fixed Asset Turnover | 3.97 | 3.47 | 2.81 | 2.71 | 3.15 |
| Asset Turnover | 1.11 | 0.99 | 0.89 | 0.83 | 0.97 |
| Working Capital Turnover Ratio | 3.47 | 3.40 | 2.98 | 2.62 | 3.36 |
| Cash Conversion Cycle | 20.64 | 0.81 | 35.10 | 73.33 | 97.07 |
| Days of Sales Outstanding | 32.53 | 43.64 | 28.18 | 59.37 | 58.56 |
| Days of Inventory Outstanding | 34.06 | 102.75 | 44.35 | 67.60 | 74.06 |
| Days of Payables Outstanding | 45.94 | 145.58 | 37.44 | 53.64 | 35.56 |
| Operating Cycle | 66.58 | 146.39 | 72.54 | 126.97 | 132.62 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 13.63 | 35.81 | 31.79 | 24.44 | 21.44 |
| Free Cash Flow Per Share | 12.31 | 27.41 | 20.11 | 16.19 | 14.29 |
| Dividend Paid and CapEx Coverage Ratio | 1.28 | 1.36 | 1.07 | 1.05 | 0.97 |
| Capital Expenditure Coverage Ratio | 10.36 | 4.26 | 2.72 | 2.96 | 3.00 |
| Operating Cash Flow Coverage Ratio | 4.27 | 7.75 | 3.96 | 5.55 | 5.48 |
| Operating Cash Flow to Sales Ratio | 0.26 | 0.28 | 0.29 | 0.25 | 0.19 |
| Free Cash Flow Yield | 3.52% | 11.39% | 3.31% | 3.77% | 1.84% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 34.04 | 13.92 | 45.23 | 35.27 | 23.28 |
| Price-to-Sales (P/S) Ratio | 6.69 | 1.87 | 5.60 | 4.32 | 6.96 |
| Price-to-Book (P/B) Ratio | 9.48 | 2.35 | 6.08 | 4.26 | 7.79 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 28.40 | 8.78 | 30.19 | 26.55 | 54.25 |
| Price-to-Operating Cash Flow Ratio | 25.65 | 6.72 | 19.09 | 17.59 | 36.16 |
| Price-to-Earnings Growth (PEG) Ratio | -0.84 | 0.48 | 4.37 | -0.56 | 0.42 |
| Enterprise Value Multiple | 20.95 | 6.34 | 21.83 | 17.41 | 15.55 |
| Enterprise Value | 55.62B | 12.92B | 32.34B | 22.80B | 41.08B |
| EV to EBITDA | 20.95 | 6.34 | 21.83 | 17.41 | 15.55 |
| EV to Sales | 6.71 | 1.88 | 5.65 | 4.33 | 6.98 |
| EV to Free Cash Flow | 28.46 | 8.82 | 30.50 | 26.62 | 54.35 |
| EV to Operating Cash Flow | 25.71 | 6.75 | 19.29 | 17.63 | 36.22 |
| Tangible Book Value Per Share | 29.88 | 81.24 | 80.21 | 82.04 | 80.44 |
| Shareholders’ Equity Per Share | 36.88 | 102.35 | 99.90 | 100.97 | 99.56 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.38 | 0.28 | 0.27 | 0.23 |
| Revenue Per Share | 52.22 | 128.67 | 108.46 | 99.53 | 111.34 |
| Net Income Per Share | 10.27 | 17.13 | 13.42 | 12.19 | 33.30 |
| Tax Burden | 0.77 | 0.63 | 0.74 | 0.73 | 0.77 |
| Interest Burden | 1.03 | 0.98 | 0.95 | 0.96 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.11 | 0.11 | 0.06 | 0.04 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.04 | 0.03 | 0.04 | 0.00 |
| Income Quality | 1.33 | 1.30 | 2.37 | 1.48 | 0.50 |
Currency in INR
